Post Market Surveillance to Observe Safety of Prevenar13™ in Adults

CompletedOBSERVATIONAL
Enrollment

659

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Pneumococcal Disease
Interventions
BIOLOGICAL

Non-intervention

Non-intervention

Trial Locations (27)

24253

Chuncheon Sacred Heart Hospital-Hallym University, Gangwon-do

35015

Chungnam National University Hospital (CNUH), Jung-gu

41931

Keimyung University Dongsan Hospital, Daegu

49241

Pusan National University Hospital, Busan

61469

Chonnam National University Hospital, Gwangju

463-823

Bundang 21st Clinic, Seongnam-si

Bundang 21st Clinic, Gyeonggi-do

152-893

Lee soo yang Internal Medical Clinic, Guro-gu

616-820

Hansarang Internal Medicine Hospital, Busan

135-830

Shin Clinic Internal Medicine, Seoul

602-739

Pusan National University Hospital, Busan

300-826

Samsung Happy Clinic, Daejeon

301-721

Chungnam National University Hospital, Daejeon

301-812

Pusan National Univeristy Hospital, Daejeon

302-120

MiSo Medical, Daejeon

305-509

Sun's internal medicine, Daejeon

Techno Internal Medicine Clinic, Daejeon

501-190

Dr. Lee's Medical Clinic, Gwangju

501-757

Chonnam National University Hospital, Gwangju

441-885

Suh Jeong Min Clinic, Gyeonggi-do

Unknown

Light & Salt Internal Medicine, Gyeonggi-do

GF Internal Medicine, Seoul

Jong Koo Lee Heart Clinic, Seoul

122-823

Seoul Samsung Medical Clinic, Seoul

139-716

Dr. Lee's Clinic of Internal Medicine, Seoul

153-806

Sung's Medical Clinic, Seoul

682-714

Ulsan University Hospital, Ulsan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01834222 - Post Market Surveillance to Observe Safety of Prevenar13™ in Adults | Biotech Hunter | Biotech Hunter